Detalles de la búsqueda
1.
Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study.
BMC Infect Dis
; 24(1): 57, 2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191304
2.
In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
J Antimicrob Chemother
; 76(8): 2097-2105, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860309
3.
Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28115351
4.
Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
Antimicrob Agents Chemother
; 60(5): 3215-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26953203
5.
A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii.
Pak J Pharm Sci
; 27(3): 463-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24811802
6.
Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study.
Ann Med
; 56(1): 2313062, 2024 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38354691
7.
Disseminated cryptococcosis initially presenting as cellulitis in a patient suffering from nephrotic syndrome.
BMC Nephrol
; 14: 20, 2013 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23336386
8.
Evaluation of the Efficacy of Optimized Two-Step-Administration Therapy with Ceftazidime/Avibactam for Treating Extensively Drug-Resistant Pseudomonas aeruginosa Pulmonary Infections: a Pharmacokinetic/Pharmacodynamic Analysis.
Jpn J Infect Dis
; 76(1): 1-6, 2023 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908879
9.
Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa.
Front Cell Infect Microbiol
; 13: 1023948, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37457958
10.
In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia.
Infect Drug Resist
; 16: 6005-6015, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37705512
11.
Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker.
Infect Drug Resist
; 15: 4467-4470, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983297
12.
Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.
J Glob Antimicrob Resist
; 27: 67-71, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34428596
13.
Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
PLoS One
; 16(10): e0258426, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648556
14.
[Antimicrobial resistance and genotyping of Acinetobacter baumannii in ICU].
Zhonghua Jie He He Hu Xi Za Zhi
; 33(9): 656-9, 2010 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-21092631
15.
Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
Infect Dis (Lond)
; 50(7): 507-513, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29316830
16.
Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Int J Antimicrob Agents
; 49(5): 609-616, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315729
17.
Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
PLoS One
; 11(3): e0152132, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26999818
18.
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.
Medicine (Baltimore)
; 95(11): e3126, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26986165
19.
Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.
Sci Rep
; 6: 39481, 2016 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27991579
20.
Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
Int J Antimicrob Agents
; 47(2): 107-16, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26742726